Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia Trial (LAMPET)

This study has suspended participant recruitment.
(Lack of funding)
Sponsor:
Information provided by (Responsible Party):
Michael Belfort, Baylor College of Medicine
ClinicalTrials.gov Identifier:
NCT00293735
First received: February 16, 2006
Last updated: January 21, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: December 2020
  Estimated Primary Completion Date: June 2020 (Final data collection date for primary outcome measure)